Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Start lubing for tomorrow’s pounding.
Might hit new 52 weeks low with Love from Russia.
Guaranteed, unfortunately.
Amen.
Been here since 2015 as well when it was pennies on the OTC. Supported when all my shares got reversed split.
After 7 years of continuous buying and holding, I don’t want to hear anything about being impatient.
Missling = Lack of Transparency
What about SAS Down Under for ALZ??
What about Material Transfer agreement with Biogen??
Absolutely NOTHING!!
Time for him to pack his bags and get a damn haircut!! That s#it looks so unprofessional.
They keep flashing $151M in the Bank, but nothing new has started!!!
I would be pedal to the metal recruiting and increasing shareholders value potential
Lack of Transparency and trustworthiness on meeting commitments and Milestones hence declining stock price.
Zero German Precision.
Closer to $1.249 than $1,249
Excellence trial hasn’t finished recruiting.
ALZ TLD might be until Dec2022/Jan2023.
PDD no mention on when Peer Review will
Be published.
AF probably already preparing next hit pieces for Excellence and ALZ.
“Our timing” I would blame them Management for not updating website and letting shareholders know.
We trade where we are due to lack of transparency.
What’s the other secret application Anavex wants to pursue? Stop mystery madness and inform shareholders before we crash under $10
Anavex should bring a Top Level CEO that increases shareholders wealth, not just his pockets with high salaries and free options. A Top Level CEO that inspires Confidence and delivers on revenue, partnerships and drug approval.
It boggles my mind how even after a successful Ph3 we still barely above single digits. Price targets keep rising and it means nothing to the SP.
Dayum, they sure stole alot of cheapies on this last attack.
Same thing with miss Sara from Spain when we had CT there.
Paid pumpers? IDK
Jack of all trades, Master of None
Watch it hit 52 weeks low once Missling opens his mouth with no concrete plan until ALZ readout Nov 2022.
Great Data, poor execution by Management. Anavex fiduciary duty is to protect Shareholders. Hope they have something ready by tomorrow, but rather keep my hopes low.
Missling, "We hope you are as excited as we are" about me getting more cheap options.
Lol, that’s the only constant here and the never ending downtrend.
Don’t believe everything you read in the internet. A lot of posers in here.
Is not anger, but frustration with Management with misteps this late in the game. I’ve supported this company since it was cents in the OTC, therefore the frustration as it trails back into single digits.
Short selling ANTS just ate our lunch last week. $250M to be exact.
Agree with you. High probability of dropping again on Excellence and ALZ ph3 regardless of results. It’s a lose-lose
Situation for Shareholders right now under Missling.
We need Management to be prepared for another short and distort attack. Enough is enough, we have lost $1.7BILLIONS in MC after our ATH of $31.5. All Missling could do is a 4th grader response saying what AF said was not true. Grow some balls, use cash reserve and lawyer up. Enough is enough after years dilution, short attacks and reverse splits!! Protect Shareholders for once instead of your damn options!!!
Based on company’s terrible track record on Milestones I would agree with you on next year for Excellence readout. As a matter of fact, market for Rett is so small that AF already has his prewritten Tweet ready to destroy any positive results.
All these speculation is nice, but right now we are fighting to stay above $10
Please stop
We’ve done plenty supporting this company for 6+ years buying thru downturns. Now is time for Missling to grow some balls and if accusations are false prosecute them.
We have los $250M in Market Capital and all Anavex could reply was: “that’s not true”. Seriously, reminds me when fighting my brother as a kid and when accused of something I just told my mom that’s not true.
Huge liability since we nose dive every time he speaks. As a matter of fact I zoned out on this last conference call until Dr Hammond began speaking. He sounded more assuring clear and crisp.
This last PR has cost ~$200M in MC and downtrend continues.
Great, Looks like Anavex is getting sued by Block/Levinton for changing endpoints.
Still no answer from Missling
Missling needs to go.
He has terrible communication skills and Shareholders pay the price.
Take legal action and PR clarification about this misunderstanding, stop blaming the CRO. Grow some balls!!
Will test $10.85 support level.
Then into single digits next week as Market loses any remaining credibility it had on Missling.
Great Science,Terrible Leadership.
$12 AH.
Market turmoil and Missling’s incompetence keeps punishing Long term investors.
ANVS already got FDA approval for Parkinson ph3 and we haven’t even seen complete results from our ph2.
FAIL.
Like always.
Lol, quit smoking crack.
He has yet to deliver Avatar around the corner
Missing timelines has brought us to the worst timing in Market for data release. I agree with you, small pop and back to red until we hear from ALZ readout “around year end” wink wink 2023...
Missling=Unsuccessful in German too.
Not surprised at all.
CEO has zero credibility on WS.
Impressive we still trust him.
Honey Badger this is so depressing.
People expected $35-40 with upcoming “pivotal” results and now we are hoping we can reach $20.
So many missed timelines have punished longs
Probably so.
3-71 is 7 years from being anything.
Specially voice of the company. Didn’t he said year “2001”for results in a conference call?
We deserve better than this
Maybe a spike and usual sell off back to $19-20